Proteomic Profile Regulated by the Anticancer Peptide CIGB-300 in Non-Small Cell Lung Cancer (NSCLC) Cells-Reference-Cited by-同舟云学术

Proteomic Profile Regulated by the Anticancer Peptide CIGB-300 in Non-Small Cell Lung Cancer (NSCLC) Cells

Published:2010-09-14 Issue:10 Volume:9 Page:5473-5483
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Rodríguez-Ulloa Arielis¹,Ramos Yassel¹,Gil Jeovanis¹,Perera Yasser¹,Castellanos-Serra Lila¹,García Yairet¹,Betancourt Lázaro¹,Besada Vladimir¹,González Luis J.¹,Fernández-de-Cossio Jorge¹,Sanchez Aniel¹,Serrano Joem M.¹,Farina Hernán¹,Alonso Daniel F.¹,Acevedo Boris E.¹,Padrón Gabriel¹,Musacchio Alexis¹,Perea Silvio E.¹

Affiliation:

1. Department of Bioinformatics, Deparment of Proteomics, and Laboratory of Molecular Oncology, Center for Genetic Engineering and Biotechnology, Havana, Cuba, and Laboratory of Molecular Oncology, National University of Quilmes, Buenos Aires, Argentina

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr100728v

Reference79 articles.

1. Nuclear localization of protein kinase CK2 catalytic subunit (CK2α) is associated with poor prognostic factors in human prostate cancer

2. Protein kinase CK2 in mammary gland tumorigenesis

3. Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia

4. Casein Kinase II Alpha Subunit and C1-Inhibitor Are Independent Predictors of Outcome in Patients with Squamous Cell Carcinoma of the Lung

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review;Journal of Developmental Biology;2022-07-27

2. Advancement and Strategies for the Development of Peptide-Drug Conjugates: Pharmacokinetic Modulation, Role and Clinical Evidence Against Cancer Management;Current Cancer Drug Targets;2021-11-18

3. Investigation of cancer drug resistance mechanisms by phosphoproteomics;Pharmacological Research;2020-10

4. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review);International Journal of Oncology;2020-07-10

5. CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome;Molecular and Cellular Biochemistry;2020-05-13